News and Events

Are you using the right reagents for Hemophilia testing?

Hemophilia testing is complicated – DiaPharma scientists can help you choose the right assays for your testing needs. We offer a variety of kits and reagents to measure FVIII and FIX. Contact us to learn more.

Factor VIII, IX, vWF, XIII hemophilia measurement assay test kit

COAMATIC® FVIII (K822585)

COATEST® SP FVIII (K824086)

COATEST® SP4 FVIII (K824094)

● Contains bovine FIXa + FX reagents

● FDA-cleared

Technochrom FVIII 2G on Ceveron® s100*

● Automated sensitive FVIII assay

Technoclone Factor FVIII Inhibitor (Bethesda)*fully automated coming soon!

Ceveron® TGA RB on Ceveron® s100*

● Automated, standardized thrombin generation assay

● Optimized for measurement of bleeding tendency, hemophilia research & development

● Explore thrombin generation assay options on the Ceveron s100

ROX FIX*

● Chromogenic FIX for Hemophilia B research

● Accurate and easy to use

*For research use only in US and Canada. Not for use in diagnostic procedures.

Solutions for Detection of Apoptosis in Oncology Xenograft Models

At DiaPharma, we specialize in biomarker assays designed to advance oncology research. One of the hallmarks of cancer is the evasion of apoptosis by tumor cells—making the detection of cellular death, especially apoptosis, a critical readout in the evaluation of anti-cancer therapies.

Xenograft models are widely used in oncology research to study cancer therapies in vivo. However, methods for evaluating the effect of potential drug candidates on tumor growth—such as volume measurements, imaging, or immunohistochemical staining—are often imprecise, expensive, technically demanding, or require sacrificing the xenograft host.

An alternative is the M30 Apoptosense® ELISA*.

P10011 VLV Peviva M30 Apoptosense ELISA measurement assay detection reagent test kit

What is the M30 Apoptosense® ELISA?

This blood-based biomarker assay utilizes the M30® antibody which specifically detects a caspase-cleaved fragment of cytokeratin 18 (CK18), a cytoskeletal protein expressed in epithelial cells and cleaved by caspases early during apoptosis. The cleaved CK18 fragment (ccK18) is released into the bloodstream, and its concentration in serum or plasma measured with the M30 Apoptosense® ELISA correlates with the extent of epithelial cell apoptosis.

Why choose the M30 Apoptosense® ELISA for use with your xenograft model?

● The M30® antibody is highly specific for human ccK18 and does not cross-react with murine proteins, enabling precise detection of apoptosis of human tumor cells with xenograft models.

● Minimally invasive blood sampling allows for longitudinal assessment of treatment response.

● The assay provides sensitive, quantitative measurements to evaluate dose- and time-dependent effects of potential drug candidates.

● Incorporating the M30® biomarker offers a robust, translational tool to strengthen efficacy assessments — particularly valuable for bridging preclinical findings to clinical applications.

We would be happy to provide more detailed information tailored to your research. Please don’t hesitate to reach out to our Scientists or your local DiaPharma Territory Manager.

*For research use only in US and Canada. Not for use in diagnostic procedures.

  • What’s New at DiaPharma?

    Posted: August 15, 2022

    It’s Not Just Support. It’s Solutions. Meet Genesis Cautivar West Territory Manager Genesis Cautivar joined DiaPharma in July 2022. He is a native of Vancouver, British Columbia, Canada and currently resides in the Dallas-Fort Worth, Texas Metroplex. He received his B.S. in Medical Technology from Walla Walla University (WA). He has many years of experience…

    Read More

  • Exploratory Biomarkers for Acute and Chronic Kidney Injury Studies

    Posted: June 28, 2022

    It’s Not Just Support. It’s Solutions. Spotlight on Acute and Chronic Kidney Injury Enhanced assays with improved sensitivity and specificity to assist in kidney disease studies L-FABP ● NGAL ● Osteopontin ● alpha-GST ● Cystatin C ● RBP4 ● Anti-EHEC There are large gaps in the information that standard kidney markers, like serum creatinine, can…

    Read More

  • CHROMOGENIC FACTOR X ASSAYS vs the PT/INR TO MONITOR SUBJECTS ON COUMADIN THERAPY WHEN AN INDIVIDUAL APPROACH IS NECESSARY

    Posted: June 28, 2022

    INTRODUCTION In a previous CLOT CLUB blog post I discussed how chromogenic factor X assays (CFX) were more accurate and less likely to be influenced in certain instances than using the prothrombin time/international ratio assay (PT/INR)1.  The PT/INR may be falsely elevated in the presence of lupus anticoagulants (LA), direct thrombin inhibitors (DTI), and dysfibrinogenemia. …

    Read More

  • News from the front lines at SOT 2022: Checkpoint Inhibitor Liver Toxicity

    Posted: June 7, 2022

    It’s Not Just Support. It’s Solutions.   Spotlight on Liver Toxicity: Immune-mediated Liver Injury Caused by Checkpoint Inhibitors (ILICI) One thing that jumped out at the Society of Toxicology (SOT) meeting this past March was a new phase of liver toxicology research focused on therapies that have a direct effect on immune function, specifically, hepatotoxicity…

    Read More

  • Measure True Beta Cell Dysfunction with TECO Intact Proinsulin

    Posted: June 6, 2022

    It’s Not Just Support. It’s Solutions. When it comes to measuring pancreatic Beta cell function, go with the Pro! TECO® Intact Proinsulin ELISA Save time and guess work by selectively measuring only intact proinsulin. Proinsulin is synthesized in pancreatic β-cells and secreted as insulin. Insulin resistance (IR) or hyperglycemia causes increased secretion and finally secretion…

    Read More

  • T-TAS®01 – The Leading Edge in Platelet Thrombus Formation Assessment

    Posted: June 1, 2022

    It’s Not Just Support. It’s Solutions. Innovative Total Platelet Function Analysis using Whole Blood Global evaluation of overall hemostatic ability using physiologic, flow conditions Exclusively from DiaPharma. Advantages of T-TAS® 01 PL Assay Ease of Interpretation A numeric cut-off easily identifies those with primary hemostasis disorders, assisting with more timely determination of appropriate treatment strategy…

    Read More

  • Respiratory Research Solutions from DiaPharma

    Posted: May 16, 2022

    It’s Not Just Support. It’s Solutions. DiaPharma is Your Exclusive Source for ProAxsis products   Reach out to DiaPharma’s Olivia Stricker, who will be at American Thoracic Society (ATS) 2022 in San Francisco, May 13 – 16. Elevate your clinical research data by measuring active proteases Targets: Drug development evaluating new protease inhibitors or anti-inflammatory…

    Read More

  • Comprehensive Solutions for Anticoagulation Research

    Posted: May 9, 2022

    It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to Enhance Your Anticoagulation Research Whether you’re researching vitamin K antagonists, thrombin inhibitors, FXa inhibitors, or contact pathway inhibitors, you need reliable, relevant tests. DiaPharma can help you select the right assays. Thrombin Generation Testing Manual or automated options for studying potential new anticoagulants Technothrombin® TGA*…

    Read More

  • Immune-mediated Liver Injury caused by Checkpoint Inhibitors (ILICI)

    Posted: May 5, 2022

    -Contributed by Abi Kasberg, PhD The immune checkpoint is a vital regulatory component that prevents the immune system from targeting healthy cells or developing autoimmunity. It does so via immunoreceptors that suppress T cell activity in mechanisms that protect normal, healthy cells from destruction. However, prolonged expression of immune checkpoint proteins can lead to T…

    Read More

  • What’s New at DiaPharma?

    Posted: April 28, 2022

    It’s Not Just Support. It’s Solutions. Meet Ryan McCaw Midwest Territory Manager Ryan joined DiaPharma in January of 2022. He obtained his BS in Medicine from the University of Iowa where he also completed the Medical Technology program. He was certified as a Medical Technologist with the ASCP and started his career in medical research…

    Read More

  • Emerging Biomarkers in Alcoholic Liver Disease

    Posted: April 14, 2022

    It’s Not Just Support. It’s Solutions. Non-Invasive Biomarkers for Alcoholic Liver Disease Studies Biomarkers of cell death and regeneration, inflammation, and immune response become useful tools as new potential Alcoholic Liver Disease (ALD) and Alcoholic Hepatitis (AH) treatment options are investigated. Serum biomarkers can provide valuable insights into: Disease severity and progression in ALD and…

    Read More

  • Thrombin Generation Assay for Cancer Associated Thrombosis Research

    Posted: April 12, 2022

    It’s Not Just Support. It’s Solutions. Technothrombin® and Ceveron® TGA Thrombin Generation Testing for Cancer-Associated Thrombosis Research Thrombosis is a common complication for individuals with cancer. Risk varies by malignancy type, treatment approaches, and individual risk factors. Thrombin generation assays (TGA) provide a global context of thrombosis. When you want to measure thrombin generation in…

    Read More

  • COMPREHENSIVE PRIMARY HEMOSTASIS ASSESSMENTS TO DIAGNOSE AND MONITOR VWD

    Posted: April 11, 2022

    -Contributed by Abi Kasberg, PhD Von Willebrand disease (VWD) is an inherited bleeding disease that clinically presents with extended bleeding times following wounds, surgeries, nosebleeds, or during menstruation. VWD affects approximately 0.1% of people and is considered to be the most common bleeding disorder (Keesler and Flood 2017). Von Willebrand factor (vWF) is a multimer…

    Read More

  • POTENTIAL FUTURE USES FOR RECOMBINANT ADAMTS13

    Posted: March 25, 2022

    David L. McGlasson, MS, MLS(ASCP) Before reading this blog post, I invite the viewer to read the article by Abi Kasberg, PhD posted August 21, 2021 titled Thrombotic Thrombocytopenic Purpura (TTP) Clinical Trials: Targeting the needs left by current treatment options.  It’s a great review of current methods to address ADAMTS13 deficiency and discusses the…

    Read More

  • Assays for your Gene Therapy Research in Rare Diseases

    Posted: March 3, 2022

    It’s Not Just Support. It’s Solutions. Explore Assays for Gene Therapy and Cell Therapy Research in Rare Diseases   HEMOPHILIA A & B Chromogenic FVIII – Coamatic® FVIII, Coatest® SP/SP4 FVIII Sensitive and reproducible, featuring bovine factor reagents Chromogenic FIX – ROX FIX* Bringing chromogenic FIX testing into the next era with unsurpassed sensitivity SICKLE…

    Read More

  • Go with the Pro – Intact Proinsulin for your Diabetes Research

    Posted: February 23, 2022

    It’s Not Just Support. It’s Solutions. When it comes to measuring pancreatic Beta cell function, go with the Pro!   TECO® Intact Proinsulin ELISA Save time and guess work by selectively measuring only active proinsulin. Only 1% to 3% of proinsulin is secreted intact. However, because proinsulin has a longer half-life than insulin, circulating proinsulin…

    Read More

  • Non-Invasive, Non-Destructive Ecotoxicology Assays

    Posted: February 23, 2022

    It’s Not Just Support. It’s Solutions. Environmental Impact Matters.   PERFORM ENDOCRINE DISRUPTOR STUDIES WITHOUT KILLING THE FISH NON-INVASIVE, EASY TO USE, ACCURATE ECOTOXICOLOGY ELISAs Use TECO® Mucus Collection Swabs and test kits to test fish: follow individuals and populations over time endocrine disruption – vitellogenin ELISA liver damage – hyaluraonic acid ELISA stress –…

    Read More

  • You Name It, I’ll Do It – complete solutions for your hemostasis needs

    Posted: February 15, 2022

    It’s Not Just Support. It’s Solutions. Ceveron® s100: Your all-in-one coagulation research analyzer Featuring automated ADAMTS13, Thrombin Generation Testing, FXIII Activity, and full menu of clotting and chromogenic tests Introducing the do-it-all Ceveron® s100, for automated hemostasis research assays. You name it, Ceveron® s100 can do it! Featuring Technofluor® ADAMTS13 as your on-demand ADAMTS13 activity…

    Read More

  • Tools for the puzzle of COVID-related coagulation

    Posted: January 26, 2022

    It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to enhance your COVID-19 Related Research *For research use only. Not for use in diagnostic procedures. Coagulation, Anticoagulation, Fibrinolysis, Thromboinflammation. DiaPharma is your resource for all things bleeding and clotting. Not sure which assays best fit your needs? Give us a call or email to…

    Read More

  • A better way to measure functionally active prothrombin

    Posted: January 13, 2022

    It’s Not Just Support. It’s Solutions. High Quality Assays for the Latest Hemostasis and Anticoagulation Research   Featuring ROX Prothrombin* Provides a prothrombinase based chromogenic method to measure biologically functional FII activity in plasma and FII containing concentrates Non-γ-carboxylated-FII is not activated in this method in contrast to snake venom based prothrombin methods High dilution…

    Read More